These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6336454)

  • 1. Artificial endocrine pancreas and diabetic nephropathy.
    Vannini P; Ciavarella A; Flammini M; Stefoni S; Bacci L; Borgnino LC
    Life Support Syst; 1983; 1 Suppl 1():41-4. PubMed ID: 6336454
    [No Abstract]   [Full Text] [Related]  

  • 2. [Continuous subcutaneous insulin infusion; the first decade].
    Doorenbos H
    Ned Tijdschr Geneeskd; 1987 Jan; 131(3):91-3. PubMed ID: 3821988
    [No Abstract]   [Full Text] [Related]  

  • 3. [Predicting diabetic nephropathy].
    Mogensen CE; Christensen CK
    Journ Annu Diabetol Hotel Dieu; 1984; ():333-49. PubMed ID: 6399537
    [No Abstract]   [Full Text] [Related]  

  • 4. The development of nephropathy in insulin-dependent diabetes mellitus is associated with poor glycemic control.
    Feldt-Rasmussen B
    Transplant Proc; 1994 Apr; 26(2):371-2. PubMed ID: 8171466
    [No Abstract]   [Full Text] [Related]  

  • 5. [Gas-forming mycosis of the kidney].
    Vorreuther R; Kuss M; Franzen W; Engelking R; Altenburg A
    Urologe A; 1993 Jan; 32(1):53-5. PubMed ID: 8447045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic hyperinsulinism induced by the use of continuous insulin infusion pumps and the artificial pancreas in diabetic patients].
    Bergua M; Levy I; Casamitjana R; Figuerola D
    Med Clin (Barc); 1983 Sep; 81(6):243-5. PubMed ID: 6358714
    [No Abstract]   [Full Text] [Related]  

  • 7. The point of no-return for the diabetic kidney is beyond clinical proteinuria.
    Selam JL; Giraud P; Mirouze J
    Diabet Med; 1984 Sep; 1(3):242. PubMed ID: 6242808
    [No Abstract]   [Full Text] [Related]  

  • 8. [Nephropathy in type-1 diabetes].
    Sawicki PT; Berger M
    Dtsch Med Wochenschr; 1993 Mar; 118(9):319-21. PubMed ID: 8444117
    [No Abstract]   [Full Text] [Related]  

  • 9. Closed-loop subcutaneous insulin infusion algorithm with a short-acting insulin analog for long-term clinical application of a wearable artificial endocrine pancreas.
    Shimoda S; Nishida K; Sakakida M; Konno Y; Ichinose K; Uehara M; Nowak T; Shichiri M
    Front Med Biol Eng; 1997; 8(3):197-211. PubMed ID: 9444512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early endocrine pancreas graft function and outcome after simultaneous pancreas-kidney transplantation.
    Troppmann C; Benedetti E; Gruessner AC; Papalois BE; Sutherland DE; Gruessner RW
    Transplant Proc; 1995 Feb; 27(1):1340-1. PubMed ID: 7878905
    [No Abstract]   [Full Text] [Related]  

  • 11. [The artificial pancreas in insulin-dependent diabetes].
    Lysy J; Globus M; Corcos A; Chowers I
    Harefuah; 1984 May; 106(9):413-4. PubMed ID: 6381260
    [No Abstract]   [Full Text] [Related]  

  • 12. [Threatened diabetic nephropathy. Early administration of ACE inhibitors and AT1 blockers].
    Einecke U
    MMW Fortschr Med; 2002 Apr; 144(15):14. PubMed ID: 12004443
    [No Abstract]   [Full Text] [Related]  

  • 13. Peripheral nerve function and metabolic control in diabetes mellitus.
    Troni W; Carta Q; Cantello R; Caselle MT; Rainero I
    Ann Neurol; 1984 Aug; 16(2):178-83. PubMed ID: 6383190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of the daily insulin requirements as determined by a biostator (artificial pancreas) in patients with insulin-dependent diabetes mellitus].
    Djurić DS; Mićić JV; Micić D; Brkić V; Nesović M; Djordjević P; Dragasević M
    Srp Arh Celok Lek; 1983; 111(9-10):1351-60. PubMed ID: 6399414
    [No Abstract]   [Full Text] [Related]  

  • 15. [Changes in kidney function in patients with diabetes mellitus during automatic correction of the blood sugar level].
    Mamaeva GG; Frenkel' VKh; Semenova MM; Sotnikova TI
    Ter Arkh; 1983; 55(6):103-6. PubMed ID: 6612610
    [No Abstract]   [Full Text] [Related]  

  • 16. Insulin therapy in renal disease.
    Iglesias P; Díez JJ
    Diabetes Obes Metab; 2008 Sep; 10(10):811-23. PubMed ID: 18248491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased renal glucose metabolism in Type 1 diabetes mellitus.
    Meyer C; Tolias A; Platanisiotis D; Stumvoll M; Vlachos L; Mitrakou A
    Diabet Med; 2005 Apr; 22(4):453-9. PubMed ID: 15787672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of the biostator (artificial pancreas) in the treatment of patients with diabetes mellitus].
    Spesivtseva VG; Mamaeva GG; Belokrinitskiĭ DV; Starosel'tseva LK; Turova EA
    Klin Med (Mosk); 1984 Oct; 62(10):55-60. PubMed ID: 6513454
    [No Abstract]   [Full Text] [Related]  

  • 19. Kidney function after improved metabolic control in newly diagnosed diabetes and in diabetic patients with nephropathy.
    Ciavarella A; Flammini M; Stefoni S; Borgnino LC; Forlani G; Bacci L; Vannini P
    Diabetes Care; 1982; 5(6):624-9. PubMed ID: 6927732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Insulin requirement in patients with type 1 diabetes with reduced renal function: human insulin versus analogue insulin].
    Hasslacher C; Vogt C; Raupp D; Dreyhaupt J
    Dtsch Med Wochenschr; 2007 Nov; 132(47):2500-4. PubMed ID: 18027324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.